Lille Model: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
* PT |
* PT |
||
Initial model was based on a study of 238 patients and published in the Journal of Hepatology in 2003.<ref>{{pmid=14647046}}</ref> Recent cohort studies demonstrate that those with a Lille score above 0.45 are likely non-responders to steroid therapy. |
Initial model was based on a study of 238 patients and published in the Journal of Hepatology in 2003.<ref>{{pmid=14647046}}</ref> Recent cohort studies demonstrate that those with a Lille score above 0.45 are likely non-responders to steroid therapy.<ref>{{pmid=17518367}}</ref> |
||
{{cite journal | title = The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. | pmid = 17518367}} |
|||
==References== |
==References== |
||
Revision as of 07:03, 5 June 2016
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
The Lille Model is a medical tool for predicting mortality in patients with alcoholic hepatitis who are not responding to steroid therapy. The model risk stratifies patients who have been receiving steroid treatment for seven days to predict who will improve and who should be considered for alternative treatment options including early referral for transplant.
The model is based on:
- Age
- Albumin
- Bilirubin (initial)
- Bilirubin (day 7)
- Creatinine
- PT
Initial model was based on a study of 238 patients and published in the Journal of Hepatology in 2003.[1] Recent cohort studies demonstrate that those with a Lille score above 0.45 are likely non-responders to steroid therapy.[2]